Reuters reports:
On at least four occasions since 2019, Elon Musk has predicted that his medical device company, Neuralink, would soon start human trials of a revolutionary brain implant to treat intractable conditions such as paralysis and blindness.
Yet the company, founded in 2016, didn’t seek permission from the FDA until early 2022 – and the agency rejected the application, seven current and former employees told Reuters.
The agency’s major safety concerns involved the device’s lithium battery; the potential for the implant’s tiny wires to migrate to other areas of the brain; and questions over whether and how the device can be removed without damaging brain tissue, the employees said.
Read the full article.
🔊 U.S. regulators rejected Elon Musk’s bid to test brain chips in humans, citing safety risks. @kimvinnell looks into @elonmusk‘s Neuralink on Reuters World News https://t.co/ghJAY1YzHz pic.twitter.com/J7AoV0hIbQ
— Reuters (@Reuters) March 2, 2023